Scientists in Switzerland have discovered that cancer cells use tiny bioparticles known as exosomes to communicate and send information via the bloodstream. This breakthrough could help in the development of cancer immunotherapy techniques.
This content was published on
2 minutes
EPFL/sb
Português
pt
Estudo revela capacidade das células cancerosas em se comunicar em longas distâncias
Exosomes are microscopic spheres less than 100 nanometres in size secreted from most cells in the body. They contain information on the form of nucleic acids, proteins and markers, and help transfer data between cells.
“It was a huge surprise, we didn’t expect to find so many melanoma cancer cell markers in blood exosomes,” said Hubert Girault, head of the Laboratory of Physical and Analytical Electrochemistry at the Federal Institute of Technology (EPFL) in Valais.
The findingsExternal link, published in the journal Chem, offer insights into how cancer cells communicate and send information around the body.
EPFL researcher Yingdi Zhu used cell culture and mass spectrometry to isolate melanoma cancer cell exosomes. She was able to identify cancer cell markers in exosomes for each stage of melanoma growth.
When analysing the blood exosomes of melanoma patients, the researchers found large quantities of cancer cell markers. The blood collects and transports all the exosomes that the body generates.
While healthy cells usually produce exosomes in small quantities, cancer cells produce many more. But it was previously thought that these would be so diluted in the blood that they would be hard to detect.
Up to now, it was thought that cancer cells were unable to communicate over longer distances within the body. This inter-cellular communication is thought to facilitate the spread of cancer cells by preparing tissue for metastasis.
The team also found that the markers offer an indication of how developed the tumour is. This means that a simple blood test, rather than a biopsy, could provide information about the presence of a tumour and its stage, and perhaps even be used to predict therapeutic responses. This would help to speed up the diagnostic process.
Popular Stories
More
Multinational companies
Azeri fossil-fuel cash cow brings controversy to Switzerland
Is artificial intelligence an advantage or a disadvantage for workers?
What is your experience with AI at work? Have you already used it? Has it helped you work better? Or has it caused you more stress, more work or caused you to lose your job? Tell us about your experiences!
Swiss price watchdog slams excessive prices for generic medicines
This content was published on
The cheapest generic medicines available in Switzerland are more than twice as expensive as in other countries, according to a study by the Swiss price watchdog.
Nature should not figure in net zero calculations: academic study
This content was published on
The natural removal of CO2 from the atmosphere by forests or oceans should not be included in the net-zero balance of climate protection measures, argue researchers.
This content was published on
None of the 15 major Swiss retail banks is meeting international climate and biodiversity targets, according to a ranking by WWF Switzerland.
This content was published on
Nestlé's new CEO Laurent Freixe, has presented plans for the future of the world's largest food company, after his first few weeks in office.
Swiss foreign minister calls on Moscow to end Ukraine war
This content was published on
It's high time Moscow ended its war against Ukraine, Swiss foreign minister Ignazio Cassis tells the UN Security Council.
This content was published on
The only alternative to the UN Palestinian agency’s work in Gaza is to allow Israel to run services there, Philippe Lazzarini, UNRWA Commissioner-General, told reporters in Geneva on Monday.
Study reveals food culture differences between Switzerland and neighbours
This content was published on
Three-quarters of Swiss people consider eating to be a pleasurable, social activity, a new survey reveals. Healthy eating, however, plays a much less important role, it found.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Roche develops tool for one-day cancer diagnosis
This content was published on
Swiss pharmaceutical company Roche has launched a diagnostic tool for breast and gastric cancer patients with specific HER2 genetic mutations.
Swiss cancer research yields breast-saving fat, better detection
This content was published on
The incidence of breast cancer in Switzerland is high, but research offers hope – especially the finding that cancer cells can be converted into fat.
This content was published on
About 40% of Geneva's residents are non-Swiss, and many speak English. ESCA helps expats diagnosed with cancer understand their treatment options.
This content was published on
Researchers in Switzerland have found a new cell type in the body’s fat depots which can actively suppress fat cell formation.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.